Hospira Recalls Propofol Injectable Emulsion Vials Due to Particulate Matter
Hospira is recalling 94,110 vials of Propofol Injectable Emulsion because a single stainless steel particulate was found during inspection.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a single particulate matter finding without reported injuries, fitting the criteria for moderate severity.
Plain-English summary
Hospira, Inc. is recalling 94,110 vials of Propofol Injectable Emulsion, 1% and 500 mg/50 mL, single-patient infusion vials. The recall was initiated after a single visible particulate, identified as stainless steel, was found during a retain sample inspection.
The affected lots are 07-950-DJ (Exp. 1JUL2013), 10-101-DJ (Exp. 1OCT2013), and 10-102-DJ (Exp. 1OCT2013). The product was distributed nationwide. The FDA has classified this recall as Class II, meaning it is a violation of labeling or manufacturing standards that could cause temporary or medically reversible health consequences.
Healthcare providers and patients should stop using the affected vials and contact Hospira or their supplier for instructions on how to return the product.
The recalled product
- Product
- PROPOFOL (PROPOFOL)
- Brand
- PROPOFOL
- Manufacturer
- Hospira Inc.
- Category
- Drug — Injectable Anesthetic
- Affected units
- 94,110
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot 07-950-DJ Exp. Date 1JUL2013
- 10-101-DJ Exp. Date 1OCT2013
- and 10-102-DJ Exp. Date 1OCT2013
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · PROPOFOL
- CriticalPropofol Injectable Emulsion Recalled for Particulate Matter Contamination
FDA (Drugs) · 2022-09-21
- SeverePropofol Injectable Emulsion Vials Recalled for Particulate Matter Contamination
FDA (Drugs) · 2022-08-03
- SevereHospira Recalls Propofol Injectable Emulsion Due to Temperature Excursions
FDA (Drugs) · 2015-02-25
- SevereHospira Recalls Propofol Injectable Vials Due to Embedded Particulate Matter
FDA (Drugs) · 2015-02-04
- SevereHospira Recalls Propofol Vials Due to Metallic Particulate Matter
FDA (Drugs) · 2014-08-27
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recall for White Screen Safety Shutdown
FDA (Devices) · 2016-11-16
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereAmerican Regent Recalls Atropine Sulfate Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereFDA Recalls Nicardipine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Multrys Trace Elements Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26